Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Valentin Angelika |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Valentin, A; Wichmann, H; Neugebauer, K; Krippl, P; Krause, R; Valentin, T Nomen est omen: acute haemolytic anaemia in a patient with persistent Staphylococcus haemolyticus bacteraemia associated with intravascular foreign material
http://www.oeginfekt.at/download/13_oeik_programm_2019_v5.pdf. 2019; -13. Österreichischer Infektionskongress ; MAR 27-30, 2019; Saalfelden am Steinernen Meer. [Poster]
FullText

 

Valentin, T; Leitner, E; Valentin, A; Krause, R; Hopkins, KL; Meunier, D; Woodford, N; Zollner-Schwetz, I Clinical Enterococcus faecalis isolate carrying the novel oxazolidinone resistance gene optrA identified in Austria
www.escmid.org. 2016; -European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); APR 9-12, 2016; Amsterdam, The Netherlands. [Poster]

 

Valentin T, Wunsch S, Leitner E, Valentin A, Rabensteiner J, Prattes J, Hoenigl M, Zollner-Schwetz I, Krause R A polyclonal outbreak of Linezolid-resistant Enterococcus faecium: risk factors and clinical impact
www.eccmid.org. 2015; -25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); APR 25-28, 2015; Copenhagen, DENMARK. [Poster]

 

Valentin,T; Wunsch,S; Leitner, E; Valentin, A; Rabensteiner, J; Prattes, J; Hoenigl, M; Zollner-Schwetz,I; Krause,R A polyclonal outbreak of Linezolid-resistant Enterococcus faecium: risk factors and clinical Impact
http://www.oeginfekt.at/download/9-oeik_programm_5.pdf. 2015; -9. Österreichischer Infektionskongress; APR 15-18, 2015; Saalfelden, Austria. [Oral Communication]

 

Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Valentin, A; Woelfler, A;Seeber, K; Strohmaier, A; Zollner-Schwetz, I; Sill H; Krause, R.. Impact of Testing Posaconazole Plasma Concentrations on Epidemiology of Antifungal Prophylaxis and Therapy in Patients with Hematologic Malignancies
. 2012; -5th Advances Against Aspergillosis; JAN 25-28, 2012; Istanbul, TURKEY. [Poster]

 

Schulz, E; Valentin, A; Ulz, P; Beham-Schmid, C; Lind, K; Rupp, V; Lackner, H; Wolfler, A; Zebisch, A; Olipitz, W; Geigl, JB; Berghold, A; Speicher, MR; Sill, H Germ-line mutations in cancer predisposing genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy-related myeloid neoplasms.
ONKOLOGIE. Onkologie. 2012; 35: 117-117.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 19-23, 2012; Stuttgart, GERMANY. [Poster]
Web of Science

 

Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Rohn, A; Seeber, K; Strohmaier, A; Woelfler, A; Zollner-Schwetz, I; Linkesch, W; Krause, R. Posaconazole Serum Levels And Invasive Fungal Infections In Patients With Hematologic Malignancies
Mycoses. 2011; 54(sup2):180-180.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 ) [Poster]
Web of Science

 

Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Strohmaier, A; Rohn, A; Seeber, K; Zollner-Schwetz, I; Woelfler, A; Krause, R Risk Factors Associated With Low Posaconazole Plasma Concentrations And Impact of Measurement On Antifungal Prophylaxis And Therapy.
Mycoses. 2011; 54(sup2):90-90.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 ) [Poster]
Web of Science

 

Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Zollner-Schwetz, I; Rohn, A; Woelfler, A; Seeber, K; Grisold, AJ; Linkesch, W; Krause, R; Posaconazole serum levels and invasive fungal infections in patients with hematologic malignancies
. 2011; -5. Österreichischer Infektionskongress; Apr 6-9, 2011; Saalfelden, Austria. [Poster]

 

Hoenigl, M; Salzer, HJ; Strohmaier, A; Valentin, T; Zollner-Schwetz, I; Rohn, A; Seeber, K; Grisold, AJ; Linkesch, W; Krause, R Risk Factors For Invasive Fungal Infection Among Patients With Hematologic Malignancies.
Mycoses. 2011; 54(sup2):51-51.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 ) [Oral Communication]
Web of Science

 

Hoenigl, M; Salzer, HJ; Valentin, T; Rohn, A; Seeber, K; Woelfler, A; Strohmaier, A; Krause, R; Impact Of Galactomannan Testing On Epidemiology Of Invasive Fungal Infection Among Patients With Hematologic Malignancies.
Mycoses. 2011; 54(sup2):145-145.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 ) [Poster]
Web of Science

 

Hoenigl, M; Salzer, HJ; Valentin, T; Zollner-Schwetz, I; Rohn, A; Woelfler, A; Strohmaier, A; Seeber, K; Sill H; Linkesch, W; Grisold, AJ; Krause, R Impact of galactomannan testing on epidemiology of invasive fungal infection among patients with hematologic malignancies
. 2011; -5. Österreichischer Infektionskongress; Apr 6-9, 2011; Saalfelden, Austria. [Poster]

 

Hoenigl, M; Salzer, HJ; Valentin, T; Zollner-Schwetz, I; Strohmaier, A; Grisold, AJ; Rohn, A; Woelfler, A; Seeber, K; Linkesch, W; Krause, R Risk factors for invasive fungal infection among patients with hematologic malignancies.
. 2011; -5. Österreichischer Infektionskongress; Apr 6-9, 2011; Saalfelden, Austria. [Poster]

 

Krause R; Zollner-Schwetz I; Valentin T; Salzer H; Hönigl M; Auner H Which Lumen is the Main Source of Catheter Related Bloodstream Infection in Multilumen Central Venous Catheters?
Abstractbook and Abstract CD. 2011; -Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); Sept 17-20, 2011; Chicago. [Poster]

 

Schulz E, Rohn A, Hiden K, Wölfler A, Beham-Schmid C, Guelly C, Lackner H, Geigl J, Speicher M, Sill H Germ-line mutations in the DNA damage response and repair genes BRCA1, BARD1 and TP53 in patients with therapy-related myeloid neoplasms.
Haematologica 2011. 2011; 96(S2):25--Annual Meeting of the European Hematology Association; JUNE 2011; London, UK. [Poster]

 

Schulz, E; Rohn, A; Lind, K; Woelfler, A; Beham-Schmid, C; Guelly, C; Lackner, H; Geigl, J; Speicher, M; Sill, H Keimbahnmutationen in den DNA-Reparatur und Apoptose-induzierenden Genen BRCA1, BARD1 und TP53 bei Patienten mit Therapie-assoziierten myeloischen Neoplasien.
OeGHO Frühjahrstagung (Young Investigator Meeting); MAY, 5-7, 2011; Pörtschach, AUSTRIA. 2011. [Oral Communication]

 

Valentin, T; Neumeister, P; Pichler, M; Rohn, A; Koidl, C; Haas, D; Heiling, B; Asslaber, MA; Zollner-Schwetz, I; Hoenigl, M; Salzer, HJF; Krause, R; Buzina, W Voriconazole-resistant disseminated mould infection: First case of Geosmithia argillacea in a hematopoetic stem cell transplant recipient.
2011; -5. Österreichische Infektionskongress (ÖGI); APR 6-9, 2011; Saalfelden, AUSTRIA. [Oral Communication]

 

Zinke-Cerwenka, W; Rohn, A; Posch, U; Beham-Schmid, C; Linkesch, W; Wölfler, A; Sill, H Graft-versus-primary malignancy in patients with therapy-related myeloid neoplasms (t-MNs) undergoing reduced-intensity allogeneic hematopoietic stem cell transplantation (HSCT).
Onkologie. 2011; 34(6):274-274.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel. [Poster]
Web of Science

 

Zinke-Cerwenka W, Rohn A, Posch U, Beham-Schmid C, Linkesch W, Wölfler A, Sill H. Allogeneic stem cell transplantation with reduced intensity conditioning in patients with therapy-related myeloid neoplasms
European Surgery. 2011; 43, Suppl. 242: 22--Annual Meeting of the Austrian Society of Transplantation, Transfusion and Genetics; Oktober 2011; Graz. [Oral Communication]

 

Neumeister, P; Schmidt, H; Linkesch, W; Pfeilstocker, M; Rohn, A SAFETY AND TOLERABILITY OF INTRATHECAL LIPOSOMAL CYTARABINE AS CNS PROPHYLAXIS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
HAEMATOL-HEMATOL J. 2010; 95: 0621 -15th Congress of the European Hematology Association.; JUNE 10-13; Barcelona, SPAIN. [Poster]
Web of Science

 

Valentin, T; Leitner, E; Rohn, A; Zollner-Schwetz, I; Hoenigl, M; Salzer, HJF; Krause, R; Rifaximin intake leads to development of rifampicin-resistant staphylococci in healthy volunteers
4. Österreichischer Infektionskongress (OeGI) 2010; MAI 05-08, 2010; Saalfelden, AUSTRIA. 2010. [Poster]

 

Valentin, T; Schmidt, H; Rohn, A; Zollner-Schwetz, I; Hoenigl, M; Salzer, HJF; Buzina, W; Krause, R Topische und systemische Therapie einer Fusarium solani-Infektion bei einem neutropenischen Patienten.
MYCOSES2010; 53(5):415-416.-44. Wissenschaftliche Tagung der DMykG gemeinsam mit der ÖGMM; SEPT 9-11, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Zinke-Cerwenka, W; Stojakovic, T; Rohn, A; Ziegler, I; Emberger, W; Sipurzynski, S; Linkesch, W; Neumeister, P First-line treatment with bortezomib, doxorubicine and dexamethasone followed by autologous peripheral blood stem cell transplantation in newly diagnosed patients with multiple myeloma
BONE MARROW TRANSPLANT. 2010; 45(2):S149-S149.-36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Rohn, A; Sormann, S; Linkesch, W; Strunk, D Radioimmunotherapy as an Effective and Safe Therapeutic Option in Patients with Extensively Pretreaed Follicular Lymphoma.
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie2009; 32(4):226-227.-Deutsches Gesellschaft für Hämatologie und Onkologie; OCT 2-6, 2009; Heidelberg / Mannheim, GERMANY. (ISBN: 978-3-8055-9351-9 ) [Oral Communication]

 

Zach, J; Zollner-Schwetz, I; Zebisch, A; Rohn, A; Krause, R Mikrobiologisches Screening zur Detektion von Katheter-assoziierten Bakteriämien/Fungämien bei Patienten im Rahmen einer hämatopoetischen Stammzelltransplantation.
. 2008; 120(15): A48 [Poster]
Web of Science

 

Zach, J; Zollner-Schwetz, I; Zebisch, A; Rohn, A; Krause, R Microbiological screening of catheter related blood stream infections in patients receiving HSCT
Interscience Conference on Antimicrobial Agents and Chemotherapy; October 2008; Washington, USA. 2008. [Poster]

 

Neumeister, PN; Pfeilstocker, M; Linkesch, W; Rohn, A Safety and tolerability of intrathecal liposomal cytarabine as cns prophylaxis in patients with acute lymphoblastic leukemia
HAEMATOL-HEMATOL J. 2007; 92: 8-9. [Poster]
Web of Science

 

Rohn A; Brezinschek, R; Sormann, S; Strunk, D; Linkesch, W Radioimmunotherapy as a therapeutic option in patients with relapsed or refractory CD20+ non-Hodgkin Lymphoma
Onkologie2007; 30(S3):200-200.-Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 5-9, 2007; Basel. [Poster]

 

Rohn, A; Leitner, C; Brezinschek, RI; Sormann, S; Linkesch, W; Strunk, D Radioimmunotherapy as a promising therapeutic option in patients with relapsed or refractory CD20(+) non-Hodgkins lymphoma
HAEMATOL-HEMATOL J. 2007; 92: 278-278.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

Rohn, A; Leitner, C; Ulreich, R; Wassertheurer, S; Brezinschek, RI; Bauer, F; Lipp, RW; Strunk, D; Linkesch, W Yttrium-90 Ibritumomab as possible therapeutic strategy in elderly and extensively pretreated patients with CD20+ Non Hodgkin Lymphoma
Wiener Medizinische Wochenschrift; 157(121):27-28.-Frühjahrestagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2007; Wien. [Poster]

 

Leitner, C; Rohn, A; Brezinschek, RI; Strunk, D; Bauer, F; Ulreich, R; Wassertheurer, S; Lipp, RW; Dorda, A; Linkesch, W Yttrium-90 ibritumomab as a possible therapeutic strategy in elderly and extensively pretreated patients with CD20+ NHL
Onkologie. 29(S3):161-161.-German, Austrian and Swiss Societies of Hematology and Oncology; NOV 4-8, 2006; Leipzig, GERMANY. [Poster]

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum